IBB (IBB) Stock Price & Analysis
IBB (IBB) rose 1.46% to USD 169.36 as of June 10, 2026 at 07:19 UTC, according to Nexqual real-time market data.
IBB last closed at USD 166.92; the session ranged USD 166.13–170.22 on volume of 2,343,408 shares. Market capitalization is —, with a 52-week range of USD 123.61–179.64 (NGM). Source: Nexqual, June 10, 2026 at 07:19 UTC.
Key Statistics (as of June 10, 2026 at 07:19 UTC)
| Price | USD 169.36 |
|---|---|
| Change | ▲ 1.46% (up) |
| Previous Close | USD 166.92 |
| Open | USD 168.1 |
| Day Range | USD 166.13 – 170.22 |
| 52-Week Range | USD 123.61 – 179.64 |
| Volume | 2,343,408 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (IBB)
Nexqual's technical model rates IBB "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 07:19 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.5 (neutral) |
| vs SMA50 | Below (USD 169.86) |
| MACD | -0.42 (negative) |
Financial Health Score (IBB)
Nexqual rates IBB's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 07:19 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XBI | State Street SPDR S&P Biotech E | USD 131.38 | ▲ 2.11% |
| XLV | State Street Health Care Select | USD 154.57 | ▲ 1.02% |
| XLF | State Street Financial Select S | USD 52.46 | ▲ 0.31% |
| XLK | State Street Technology Select | USD 180.77 | ▲ 0.26% |
| XLE | State Street Energy Select Sect | USD 57.39 | ▼ 0.49% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 07:19 UTC. This page is informational and not investment advice.